Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial by Chéret, Antoine, Dr, Nembot, Georges, MD, Mélard, Adeline, MSc, Lascoux, Caroline, MD, Slama, Laurence, MD, Miailhes, Patrick, MD, Yeni, Patrick, Prof, Abel, Sylvie, MD, Avettand-Fenoel, Véronique, PharmD, Venet, Alain, MD, Chaix, Marie-Laure, MD, Molina, Jean-Michel, Prof, Katlama, Christine, Prof, Goujard, Cécile, Prof, Tamalet, Catherine, MD, Raffi, François, Prof, Lafeuillade, Alain, MD, Reynes, Jacques, Prof, Ravaux, Isabelle, MD, Hoën, Bruno, Prof, Delfraissy, Jean-François, Prof, Meyer, Laurence, Prof, Rouzioux, Christine, Prof

Get full text